CaRi-heart technology
Revolutionary new technology to assess the risk of a serious heart condition or heart attack – many years before anything happens.
Haematological malignancies. Blood cancer is a broad term used to describe types of cancer that affect the blood, bone marrow or lymphatic system
Leukaemia affects the white blood cells and starts in the bone marrow, the soft tissue inside most bones where blood cells are made. There are four main types of leukaemia and they are named based on the type of white blood cell which is affected and whether it is acute (fast growing) or chronic (slow growing).
These two types of cancers begin in a subset of white blood cells called lymphocytes and largely involve the glands (lymph nodes). The difference between Hodgkin and non-Hodgkin lymphoma is largely attributed to the cellular types involved, but there are many subtypes and the behaviour of the diseases can vary.
This cancer affects plasma cells, a type of white blood cell that is made in the bone marrow, which form part of your immune system. Usually these plasma cells produce immunoglobulins, which are antibodies which help to fight infection. Myeloma is a result of DNA which is damaged in the development of these plasma cells.
Our network of specialist centres provide expert care for blood cancers and disorders. We have a team of highly specialised consultant haematologists, senior nurses and other healthcare professionals, to ensure you get the best possible care.
All of our hospitals providing treatment for blood cancers have achieved the highest rating of 'Oustanding' from the independent health regulator The Care Quality Commission (CQC), and, each of our bone marrow and stem cell transplant services are quality assured and accredited by
JACIE — a European quality accreditation for haematopoetic stem cell transplantation (HSCT) and cellular therapy.
An allogeneic stem cell transplant, also known as a bone marrow transplant, is used to treat blood cancers and disorders using matched donor cells
A revolutionary treatment that uses the patient's own immune system to target certain types of cancer
This content is intended for general information only and does not replace the need for personal advice from a qualified health professional.